Thu, September 19, 2024
[ 12:00 AM ] - WOPRAI
Wed, August 14, 2024
[ 12:00 AM ] - WOPRAI
Wed, June 26, 2024
[ 12:00 AM ] - WOPRAI
Fri, June 21, 2024
[ 12:00 AM ] - WOPRAI
Thu, June 13, 2024
[ 12:00 AM ] - WOPRAI
Fri, May 3, 2024
[ 12:00 AM ] - WOPRAI
Tue, April 16, 2024
[ 12:00 AM ] - WOPRAI
Thu, April 4, 2024
[ 12:00 AM ] - WOPRAI
Mon, March 4, 2024
[ 12:00 AM ] - WOPRAI
Fri, February 16, 2024
[ 12:00 AM ] - WOPRAI
Wed, October 25, 2023
[ 12:00 AM ] - WOPRAI
Tue, May 30, 2023
[ 12:00 AM ] - WOPRAI
Tue, March 7, 2023
[ 12:00 AM ] - WOPRAI
Tue, January 17, 2023
[ 12:00 AM ] - WOPRAI
Fri, January 6, 2023
[ 12:00 AM ] - WOPRAI
Fri, August 26, 2022
[ 12:00 AM ] - WOPRAI
Wed, May 18, 2022
[ 12:00 AM ] - WOPRAI
Wed, March 23, 2022
[ 12:00 AM ] - WOPRAI
Fri, March 11, 2022
[ 12:00 AM ] - WOPRAI
Mon, November 15, 2021
[ 12:00 AM ] - WOPRAI
Tue, August 24, 2021
[ 12:00 AM ] - WOPRAI
Fri, June 11, 2021
[ 12:00 AM ] - WOPRAI
Tue, March 16, 2021
[ 12:00 AM ] - WOPRAI
Wed, August 26, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, July 31, 2020
Yasmeen Rahimi Maintained (zura) at Buy and Held Target at $26 on, Sep 19th, 2024
Yasmeen Rahimi of Piper Sandler, Maintained "Zura Bio Limited" (ZURA) at Buy and Held Target at $26 on, Sep 19th, 2024.
Yasmeen has made no other calls on ZURA in the last 4 months.
There are 2 other peers that have a rating on ZURA. Out of the 2 peers that are also analyzing ZURA, 1 agrees with Yasmeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Mitchell Kapoor of "HC Wainwright & Co." Initiated at Hold and Held Target at $5 on, Thursday, September 5th, 2024
This is the rating of the analyst that currently disagrees with Yasmeen
- Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy on, Thursday, August 15th, 2024
Contributing Sources